Stock ALPMY ASTELLAS PHARMA INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Astellas Pharma Inc. OTC Markets

Equities

ALPMY

US04623U1025

Market Closed - OTC Markets
Other stock markets
 20:51:56 20/06/2024 BST 		5-day change 1st Jan Change
9.39 USD -1.05% Intraday chart for Astellas Pharma Inc. -2.09% -21.09%
06-03 US FDA Acknowledges Astellas Pharma's Resubmission of Biologics License Application for Zolbetuximab MT
05-31 U.S. Food and Drug Administration Acknowledges Astellas Pharma Inc.? Resubmission of Biologics License Application for Zolbetuximab and Sets New Action Date CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ELI LILLY AND COMPANY Stock Eli Lilly and Company
 798B
NOVO NORDISK A/S Stock Novo Nordisk A/S
 633B
JOHNSON & JOHNSON Stock Johnson & Johnson
 356B - - - -
MERCK & CO., INC. Stock Merck & Co., Inc.
 328B
ABBVIE INC. Stock AbbVie Inc.
 304B
  1. Stock Market
  2. Equities
  3. 4503 Stock
  4. ALPMY Stock
  5. Charts Astellas Pharma Inc.
  6. Sector Chart